The Strategic Advantage of Conducting Trials in Australia

The Strategic Advantage of Conducting Trials in Australia

Australia has emerged as one of the most attractive destinations for early clinical research, offering a combination of sophisticated infrastructure, cost-effectiveness and regulatory efficiency.

Partnering with an experienced early development partner who has an established presence in Australia can be a game-changer for companies looking to optimize their clinical trial strategies.

In this white paper, you will learn: 

• How Australia’s regulatory environment accelerates early-phase clinical trials 
• The cost efficiencies gained from conducting research in Australia, including favorable tax incentives 
• Key attributes to look for in a CRO partner 
• The importance of a physical presence in Australia to maximize trial speed and cost-effectiveness 

Learn why the PPD™ clinical research business of Thermo Fisher Scientific is the clear choice for early development services in Australia.